Woodline Partners’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10M | Buy |
445,615
+251,448
| +130% | +$5.67M | 0.05% | 434 |
|
|
2025
Q1 | $5.43M | Buy |
+194,167
| New | +$5.43M | 0.04% | 486 |
|
|
2022
Q2 | – | Sell |
-19,843
| Closed | -$4.81M | – | 905 |
|
|
2022
Q1 | $4.81M | Sell |
19,843
-10,953
| -36% | -$2.66M | 0.08% | 249 |
|
|
2021
Q4 | $9.31M | Buy |
+30,796
| New | +$9.31M | 0.13% | 206 |
|
|
2021
Q2 | – | Sell |
-6,231
| Closed | -$1.28M | – | 635 |
|
|
2021
Q1 | $1.28M | Sell |
6,231
-8,169
| -57% | -$1.68M | 0.03% | 348 |
|
|
2020
Q4 | $2.88M | Sell |
14,400
-4,759
| -25% | -$952K | 0.08% | 183 |
|
|
2020
Q3 | $3.17M | Sell |
19,159
-1,858
| -9% | -$308K | 0.1% | 152 |
|
|
2020
Q2 | $5.21M | Buy |
21,017
+7,954
| +61% | +$1.97M | 0.21% | 111 |
|
|
2020
Q1 | $2.38M | Buy |
+13,063
| New | +$2.38M | 0.17% | 113 |
|